New York State Common Retirement Fund’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

New York State Common Retirement Fund’s Portfolio NVIV Stock Details NVIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1	Closed	-$98K	–	3291
2017 Q1	$98K	Hold	1	–	–	﹤0.01%	2971
2016 Q4	$102K	Hold	1	–	–	﹤0.01%	2972
2016 Q3	$165K	Hold	1	–	–	﹤0.01%	2828
2016 Q2	$140K	Hold	1	–	–	﹤0.01%	2883
2016 Q1	$169K	Hold	1	–	–	﹤0.01%	2749
2015 Q4	$174K	Hold	1	–	–	﹤0.01%	2834
2015 Q3	$209K	Hold	1	–	–	﹤0.01%	2764
2015 Q2	$283K	Buy	+1	New	+$264K	﹤0.01%	2779

Other funds holding NVIV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ICM

IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York State Common Retirement Fund's NVIV Position: Q2 2017 in Review

New York State Common Retirement Fund sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q2 2017, closing a stake of 1 share — an estimated $98K sold.

New York State Common Retirement Fund first reported a position in NVIV in Q2 2015 and held it in 8 quarters. The position peaked at $283K in Q2 2015. 37 funds tracked by Wall St. Rank hold NVIV as of Q2 2017.

New York State Common Retirement Fund reported no remaining InVivo Therapeutics Holdings Corp position as of Q2 2017 after selling out during the quarter.
New York State Common Retirement Fund sold 1 InVivo Therapeutics Holdings Corp share in Q2 2017, an estimated $98K.
New York State Common Retirement Fund first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and held it in 8 quarters.
New York State Common Retirement Fund's InVivo Therapeutics Holdings Corp position peaked at $283K in Q2 2015.
37 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q2 2017.

Based on New York State Common Retirement Fund's 13F filing for Q2 2017, filed 11 Aug 2017.